Pharmacogenomics
Pharmacogenomics is the study of the role of the genome in drug response. Its name (pharmaco- + genomics) reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugs. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacokinetics (drug absorption, distribution, metabolism, and elimination) and pharmacodynamics (effects mediated through a drug's biological targets). The term pharmacogenomics is often used interchangeably with pharmacogenetics. Although both terms relate to drug response based on genetic influences, pharmacogenetics focuses on single drug-gene interactions, while pharmacogenomics encompasses a more genome-wide association approach, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response
Related Conference of Pharmacogenomics
17th International Conference on Tissue Science and Regenerative Medicine
Pharmacogenomics Conference Speakers
Recommended Sessions
- Applications of Genomics & Bioinformatics
- Bioinformatics
- Bioinformatics Work Flow Management Systems
- Computational Biology
- Data Mining in Genomics and Bioinformatics
- Drug Design & Development
- Epigenomics
- Evolutionary Biology
- Functional Genomics
- Genomics
- Immunomics
- Metabolomics
- Molecular Modelling
- Next Generation Sequencing
- Oncogenomics
- Pathogenomics
- Pharmacogenomics
- Phylogenetics
- Proteomics
- Structural Bioinformatics
- Structural Genomics